What Are Stem Cells?

Stem cells are undifferentiated biological cells with two defining properties: the capacity for self-renewal through cell division and the ability to differentiate into specialized cell types with distinct structural and functional characteristics. Found throughout the body from the earliest embryonic stage to mature adult tissues, stem cells serve as a biological repair and maintenance system, replacing cells lost to normal turnover, injury, and disease. Their study spans cell biology, developmental biology, genetics, and biomedical engineering, and their therapeutic potential has made them a central focus of regenerative medicine research since the isolation of human embryonic stem cells in 1998.

The field distinguishes stem cells from progenitor cells, which are partially committed precursors that have lost some developmental plasticity but retain the ability to produce several specialized cell types. Progenitor cells serve as intermediates in differentiation cascades, bridging the gap between multipotent stem cell pools and fully differentiated tissue cells such as neurons, cardiomyocytes, or red blood cells. Cloning by somatic cell nuclear transfer represents a distinct but related technology that generates embryos with a specified nuclear genome; while it can produce embryonic stem cells, the approach differs mechanistically from stem cell reprogramming and raises separate ethical and regulatory considerations.

Types of Stem Cells

Stem cells are classified by their developmental potential. Totipotent cells, present only in the first few divisions after fertilization, can give rise to every cell type in both the embryo and the extraembryonic tissues. Pluripotent stem cells, including human embryonic stem cells (hESCs) derived from the inner cell mass of blastocysts, can differentiate into any cell type of the three primary germ layers but cannot form extraembryonic structures. Multipotent stem cells, such as hematopoietic stem cells in bone marrow, are restricted to producing the specialized cell types of a single tissue lineage. Comparison of human induced pluripotent and embryonic stem cells finds that the two pluripotent cell types share gene expression profiles, epigenetic marks, and differentiation potential, while differing in subtle methylation patterns that reflect their distinct cellular origins.

Induced Pluripotent Stem Cells

Induced pluripotent stem cells (iPSCs) are generated by reprogramming differentiated adult cells, typically skin fibroblasts or peripheral blood cells, back to a pluripotent state by introducing a defined set of transcription factors. The technique was first demonstrated in mouse cells by Shinya Yamanaka's group in 2006 and extended to human cells the following year, work recognized by the 2012 Nobel Prize in Physiology or Medicine. Because iPSCs carry the patient's own genome, they can be used to generate disease-specific cell lines for modeling genetic disorders without immune compatibility barriers. Research on iPSC molecular mechanisms and applications describes how reprogramming erases epigenetic marks associated with the original cell type and re-establishes the pluripotent transcriptional network, a process that typically takes two to four weeks using viral or non-integrating vector delivery of the reprogramming factors OCT4, SOX2, KLF4, and c-MYC.

Progenitor Cells and Lineage Commitment

The transition from a stem cell to a mature specialized cell proceeds through progenitor stages in which developmental options are progressively narrowed. In the hematopoietic system, pluripotent hematopoietic stem cells give rise to common myeloid and lymphoid progenitors, which in turn produce more restricted progenitors committed to specific blood cell types. Signals from the extracellular microenvironment, or niche, regulate when stem cells divide symmetrically to expand the stem cell pool versus asymmetrically to produce a daughter committed to differentiation. Studies of iPSC potential for basic and clinical sciences document how directed differentiation protocols that mimic the signaling milieu of embryonic development can drive iPSCs through defined progenitor intermediates toward clinically relevant cell types including neurons, cardiomyocytes, and pancreatic beta cells.

Applications

Stem cells have applications in a wide range of fields, including:

• Regenerative medicine and cell therapy for heart disease, Parkinson's disease, and diabetes
• Patient-specific disease modeling and drug screening using iPSC-derived cells
• Bone marrow transplantation for hematologic malignancies and immune disorders
• Toxicology testing with human cell models to reduce animal testing
• Cancer biology research, particularly the cancer stem cell hypothesis